Skip to content
Clinical Trial Events
DIA Europe

Talk Data Science, RWE & Artificial Intelligence track

S0306 - International Harmonization and Convergence in RWD

Thu, Mar 20, 2025 · 8:30–9:40 AM CET Kairo 1-2 Room, Congress Center Basel

About this session

How can we achieve global harmony in the use of real-world data (RWD) and real-world evidence (RWE)? This session will address the critical need for harmonization and convergence in RWD/RWE terminology and guidelines. Discussions will begin with the importance of a common language, as exemplified by ICH initiatives, and move on to harmonizing data quality frameworks across regulatory perspectives.

Programme:
- 2. “You Say Tomato, I Say Tomato”? Finding Regulatory Harmony in RWD/RWE Terminology and Guidelines — Bart Barefoot
- Panel Discussion — Melissa Kampman, Rachael Williams
- 3. Harmonizing Data Quality Attributes: A Comparative Analysis of EMA, FDA, and ICH M14 Guidelines — Elena Popa
- 1. Setting the scene — Patrice Verpillat, Bart Barefoot
- 4. Characteristics Impacting Authority Consideration of RWE for Effectiveness: Evidence from North America, Europe and Australia — Gianmario Candore

Speakers

  • Patrice Verpillat

    Head of Real World Evidence · European Medicines Agency

    Chair

  • Rachael Williams

    Head of Epidemiology · Medicines and Healthcare products Regulatory Agency

    Panelist

  • Melissa Kampman

    Manager and Senior Epidemiologist, Marketed Health Products Directorate · Health Canada

    Panelist

  • Bart Barefoot

    Senior Director and Head, Europe Regulatory Policy · GSK

    Chair

  • Elena Popa

    Chief of Staff, Global Regulatory Affairs · Bayer

    Speaker

  • Gianmario Candore

    Senior Partnership and Policy Manager · Bayer AG

    Speaker